Want to join the conversation?
$REGN and Sanofi conducted a largest Phase 3 analysis of patients with Familial Hypercholesterolemia that showed that by adding Praluent to standard-of-care therapy it reduced LDL-cholesterol by an avg. 56% compared to standard-of-care alone. The analysis was presented at ESC Congress 2015 and selective data was published in European Heart Journal.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?